Arginase II activity regulates cytosolic Ca2+ level in a p32-dependent manner that contributes to Ca2+-dependent vasoconstriction in native low-density lipoprotein-stimulated vascular smooth muscle cells. [PDF]
Koo BH +8 more
europepmc +1 more source
Arginase II inhibition prevents interleukin-8 production through regulation of p38 MAPK phosphorylation activated by loss of mitochondrial membrane potential in nLDL-stimulated hAoSMCs. [PDF]
Koo BH +8 more
europepmc +1 more source
<i>In silico</i> rational investigation of C-terminal arginine-containing white Lupin (<i>Lupinus albus</i>) protein-derived peptides as arginase inhibitors. [PDF]
Chukwuejim S, Fatoki TH, Aluko RE.
europepmc +1 more source
Cell-autonomous and non-cell-autonomous effects of arginase-II on cardiac aging
Potenza DM +9 more
europepmc +1 more source
The Janus face of L-arginine supplementation in cardiovascular health and aging exploration of underlying mechanisms. [PDF]
Yang Z, Ming XF, Potenza DM.
europepmc +1 more source
Alterations in Arginase Activity and Polyamine Metabolism Contribute to the Mode of Action of Canavanine in Tomato Roots. [PDF]
Staszek P, Ciacka K, Gniazdowska A.
europepmc +1 more source
Reprogramming the immunosuppressive microenvironment in glioblastoma: the microglia-MDSC-Treg axis and translational therapeutic strategies. [PDF]
Aydın HA, Keskin E, Kalaycı M.
europepmc +1 more source
Crystal structure of a cold-active arginase from Glaciozyma antarctica. [PDF]
Quay DHX +9 more
europepmc +1 more source
Cytotoxic Effects of Medicinal Plant Extracts on HeLa Cells via Redox Imbalance, L-Arginine Metabolic Reprogramming, and Glycolytic Suppression. [PDF]
Kocharyan M +6 more
europepmc +1 more source
Therapeutic Modulation of Nitric Oxide Pathways to Address Insulin Resistance in Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Ceteraș LM +10 more
europepmc +1 more source

